Common HIV drugs available in Canada for adults
Complete fixed-dose combination treatment |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Atripla |
600 mg / 200 mg / 300 mg |
|
One tablet once daily |
Take on an empty stomach |
|
Apo-Efavirenz/ |
600 mg / 200 mg / 300 mg |
|
||
|
Mylan-Efavirenz/ |
600 mg / 200 mg / 300 mg |
|
||
|
Teva-Efavirenz/ |
600 mg / 200 mg / 300 mg |
|
||
|
Biktarvy |
50 mg / 25 mg / 200 mg |
|
One tablet once daily |
No food restrictions |
|
Complera |
300 mg / 200 mg / 25 mg |
|
One tablet once daily |
Take with food |
|
Delstrigo |
100 mg / 300 mg / 300 mg |
|
One tablet once daily |
No food restrictions |
|
Dovato |
50 mg / 300 mg |
|
One tablet once daily |
No food restrictions |
|
Genvoya |
150 mg / 150 mg / 10 mg / |
|
One tablet once daily |
Take with food |
|
Juluca |
50 mg / 25mg |
|
One tablet once daily |
Take with food |
| Odefsey (rilpivirine + tenofovir alafenamide + emtricitabine) |
25 mg / 25 mg / 200 mg |  |
One tablet once daily | Take with food |
|
Stribild |
150 mg / 150 mg / 300 mg / 200 mg |
|
One tablet once daily |
Take with food |
| Symtuza (darunavir + cobicistat + tenofovir alafenamide + emtricitabine) |
800 mg / 150 mg / 10 mg / 200 mg |
 |
One tablet once daily | Take with food |
|
Triumeq |
50 mg / 600 mg / 300 mg |
|
One tablet once daily |
No food restrictions |
Other combination tablets |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Combivir |
150 mg / 300 mg |
|
One tablet twice daily |
No food restrictions |
|
Apo-Lamivudine/ |
150 mg / 300 mg |
|
||
|
Auro-Lamivudine/ |
150 mg / 300 mg |
|
||
|
Teva-Lamivudine/ |
150 mg / 300 mg |
|
||
| Descovy (tenofovir alafenamide + emtricitabine) |
10 mg / 200 mg |
 |
One tablet once daily | No food restrictions |
|
25 mg / 200 mg |
 |
|||
|
Kivexa |
600 mg / 300 mg |
|
One tablet once daily |
No food restrictions |
|
Apo-Abacavir/ |
600 mg / 300 mg |
|
||
|
Auro-Abacavir/ |
600 mg / 300 mg |
|
||
|
Teva-Abacavir/ |
600 mg / 300 mg |
|
||
|
Prezcobix |
800 mg / 150 mg |
|
One tablet once daily |
Take with food |
|
Trizivir |
300 mg / 150 mg / 300 mg |
|
One tablet twice daily |
No food restrictions |
|
Apo-Abacavir/ |
300 mg / 150 mg / 300 mg |
|
||
|
Truvada |
200 mg / 300 mg |
|
One tablet once daily |
No food restrictions |
|
Apo-Emtricitabine/ |
200 mg / 300 mg |
|
||
|
Jamp-Emtricitabine/Tenofovir |
200 mg / 300 mg |
|
||
|
Mint-Emtricitabine/Tenofovir |
200 mg / 300 mg |
|
||
|
Mylan-Emtricitabine/ |
200 mg / 300 mg |
|
||
|
PMS- Emtricitabine/Tenofovir |
200 mg / 300 mg |
|
||
|
Teva-Emtricitabine/ |
200 mg / 300 mg |
|
||
Co-receptor inhibitor |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Celsentri |
300 mg |
|
One tablet twice daily |
No food restrictions |
|
150 mg |
|
Two tablets twice daily |
||
Fusion inhibitor |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Fuzeon |
90 mg |
White powder in glass vial |
One injection twice daily |
No food restrictions |
Long-acting injectable treatment |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Cabenuva |
600 mg / 900 mg |
|
Initiation: Two injections once a month (months one and two)
Maintenance: Two injections once every two months (month four onward) |
No food restrictions |
|
600 mg / 900 mg |
||||
|
Sunlenca |
300 mg (oral) initiation dose 463.5 mg (injection) initiation dose
|
Injectable: Clear, yellow to brown liquid in a clear glass vial |
Initiation: Two tablets on days one and two One tablet on day eight Two injections on day 15
Maintenance: Two injections once every six months (26 weeks) |
|
|
Vocabria** |
30 mg |
|
One tablet once daily |
Take with food |
Integrase inhibitors |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Isentress |
400 mg |
|
One tablet twice daily |
No food restrictions |
| Isentress HD (raltegravir) |
600 mg |  |
Two tablets once daily | No food restrictions |
|
Tivicay |
50 mg |
|
One tablet once daily OR twice daily |
No food restrictions |
Non-nukes (NNRTIs) |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Edurant |
25 mg |
|
One tablet once daily |
Take with food |
|
Intelence |
100 mg |
|
Two tablets twice daily |
Take with food |
|
200 mg |
|
One tablet twice daily |
||
|
Pifeltro |
100 mg |
|
One tablet once daily |
No food restrictions |
|
Sustiva |
600 mg |
|
One tablet once daily |
Take on an empty stomach |
|
200 mg |
|
Three capsules once daily |
||
|
Auro-Efavirenz |
600 mg |
|
One tablet once daily |
|
|
Mylan-Efavirenz |
600 mg |
|
||
|
Teva-Efavirenz |
600 mg |
|
||
|
Auro-Nevirapine |
200 mg |
|
One tablet twice daily |
|
Nukes (nucleoside and nucleotide analogues, or NRTIs) |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
3TC* |
300 mg |
|
One tablet once daily |
No food restrictions |
|
150 mg |
|
One tablet twice daily |
||
|
Apo-Lamivudine |
300 mg |
|
One tablet once daily |
|
|
150 mg |
|
One tablet twice daily |
||
|
Retrovir* |
100 mg |
|
Three capsules twice daily OR two capsules three times daily |
No food restrictions |
|
Apo-Zidovudine* |
100 mg |
|
||
|
Viread |
300 mg |
|
One tablet once daily |
No food restrictions |
|
Apo- |
300 mg |
|
||
|
Auro- |
300 mg |
|
||
|
Mylan- |
300 mg |
|
||
|
Teva- |
300 mg |
|
||
|
Ziagen* |
300 mg |
|
One tablet twice daily OR two tablets once daily |
No food restrictions |
|
Apo- |
300 mg |
|
||
|
Mint- |
300 mg |
|
||
Protease inhibitors |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Aptivus++ |
250 mg |
Pink capsule, labelled "TPV 250" |
Two tablets twice daily |
Take with food |
|
Kaletra* |
200 mg / 50 mg |
|
Two tablets twice daily OR four tablets once daily |
No food restrictions |
|
Norvir*+ |
100 mg |
|
Six tablets twice daily |
Take with food |
|
Prezista* ++ |
800 mg |
|
One tablet twice daily |
Take with food |
|
600 mg |
|
|||
|
Apo-Darunavir ++ |
800 mg |
|
||
|
600 mg |
|
|||
|
Auro-Darunavir ++ |
800 mg |
|
||
|
600 mg |
|
|||
|
Reyataz++ |
300 mg |
|
One tablet once daily |
Take with food |
|
200 mg |
|
Two tablets once daily |
||
|
Mylan-Atazanavir++ |
300 mg |
|
One tablet once daily |
|
|
200 mg |
|
Two tablets once daily |
||
|
Teva-Atazanavir++ |
300 mg |
|
One tablet once daily |
|
|
200 mg |
|
Two tablets once daily |
||
Attachment Inhibitor |
||||
|
Brand name (generic name) |
Common dosage |
Image |
Dosage schedule |
Food requirements |
|
Rukobia |
600 mg |
|
One tablet twice daily |
|
* Also available in liquid formulation (not pictured)
** Taken with Edurant for one month before starting Cabenuva (optional). Food requirements refer to Edurant only. May also be taken with Edurant if injections are delayed or missed
+ Taken as booster with other HIV drugs
++ Usually taken with ritonavir
NOTE
This chart lists common daily dosing schedules. People should always follow the dosing schedule prescribed by their doctor, which may vary from those shown here.
Acknowledgements
3TC®, Cabenuva®, Celsentri®, Combivir®, Dovato®, Juluca®, Kivexa®, Retrovir®, Tivicay®, Trizivir®, Vocabria®, Ziagen® and Rukobia® are registered trademarks and Triumeq™ is a trademark of the ViiV Healthcare group of companies. Images copyright ViiV Healthcare ULC. Used with permission.
Images of Atripla®, Biktarvy™, Complera®, Descovy™, Genvoya™, Odefsey™, Stribild®, Truvada®, Viread® and Sunlenca® copyright Gilead Sciences Canada, Inc. Used with permission.
Images of Edurant®, Intelence®, Prezcobix®, Prezista® and Symtuza™ copyright Janssen Inc. Used with permission.
Images of Delstrigo™, Isentress®, Isentress® HD and Pifeltro™ copyright Merck Canada Inc. Used with permission.
Images of Auro-Abacavir/Lamivudine, Auro-Darunavir, Auro-Efavirenz, Auro-Lamivudine/Zidovudine and Auro-Tenofovir copyright Auro Pharma Inc. Used with permission.
Fuzeon® is a registered trademark of F. Hoffmann-La Roche AG.
Images of Mylan-Atazanavir, Mylan-Efavirenz, MylanEfavirenz/Emtricitabine/Tenofovir, Mylan-Emtricitabine/Tenofovir Disoproxil and Mylan-Tenofovir Disoproxil copyright Mylan Pharmaceuticals. Used with permission.
Images of Sustiva® and Reyataz® copyright BristolMeyers Squibb. Used with permission.
Images of Teva-Abacavir/Lamivudine, Teva-Atazanavir, Teva-Efavirenz, Teva-Efavirenz/Emtricitabine/Tenofovir, Teva-Emtricitabine/Tenofovir, Teva-Lamivudine/Zidovudine and TevaTenofovir copyright Teva Pharmaceutical Industries Ltd. Used with permission.
Images of Kaletra® and Norvir® copyright AbbVie Inc. Used with permission.
Aptivus®, Viramune® and Viramune XR® areis a registered trademarks of Boehringer Ingelheim International GmbH, used under license.
Images of Apo-Darunavir, Apo-Efavirenz/ Emtricitabine/Tenofovir, Apo-Abacavir/Lamivudine/Zidovudine, Apo-Lamivudine/Zidovudine, Apo-Abacavir/ Lamivudine, Apo-Emtricitabine/Tenofovir, Apo-Lamivudine, Apo-Zidovudine, Apo-Tenofovir and Apo-Abacavir are owned and copyright of Apotex Technologies Inc. Used with permission.
Images of Mint-Abacavir and Mint-Emtricitabine/Tenofovir copyright Mint Pharmaceuticals Inc. Used with permission. Image of Jamp-Emtricitabine/Tenofovir copyright Jamp Pharmaceutical Corporation. Used with permission. Image of PMS-Emtricitabine/Tenofovir copyright Pharmascience Inc. Used with permission.